New Method for the Detection of Sports-Related Brain Injury Developed By Medicortex
Every time a professional football player makes headlines because of a severe concussion sustained on the playing field, a researcher and neurobiologist Dr. Adrian Harel is reminded of the urgent need for more effective protocols to diagnose and treat traumatic brain injury (TBI). Dr. Harel and his team are intensely pursuing breakthrough rapid diagnostic test and treatments for TBI with a new class of drugs. “What so many people fail to realize is that even if a player isn’t thrown into a coma or vegetative state by the injury, TBI can have long-lasting effects that may ultimately end in tragedy.” Dr. Harel says.
Sports-related TBI among professional athletes is a serious problem. In the US alone, there are annually more than 300,000 cases where athletes are suffering from concussion and TBIs that result in loss of consciousness.
The medical community is well aware of the importance of early intervention in all forms and degrees of TBI. “We are simply seeing too many of our best athletes [ice-hockey, rugby, football, boxing ] permanently brain-damaged,” says Dr. Harel, “not to mention the millions of other cases of TBI sustained by people of all ages as a result of vehicle crashes, falls, workplace accidents, and assaults or physical abuse. TBI is a major problem in search of a comprehensive solution. With the research we are doing now, there is finally a light at the end of the tunnel.”
Medicortex is seeking investors, together with its crowdfunding campaign. Every interested individual may help the development of the diagnostic kit by participating the crowdfunding campaign at: www.invesdor.com/medicortex Medicortex is issuing shares with the goal of raising capital that matches the other half that the firm has already applied for from the Finnish Funding Agency for Innovation (Tekes).
Medicortex Finland Oy (http://www.medicortex.fi ) is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). Its current focus is to develop biomarker diagnostics that evaluate the extent and severity of TBI. Once the company completes this test its next goal will be to develop an innovative drug to halt the progression of brain injury.
Key words: NFL, ice-hockey, rugby, brain injury, head injury, concussion, diagnostics, TBI, sport, professional athletes, boxing, early detection
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
LOXAM20.7.2018 16:53 | pressemeddelelse
Loxam Announces a Conditional Agreement to Acquire UK Platforms
SCHLUMBERGER-LIMITED20.7.2018 13:02 | pressemeddelelse
Schlumberger Announces Second-Quarter 2018 Results
FL-H.I.G.-CAPITAL19.7.2018 21:52 | pressemeddelelse
H.I.G. Capital Announces the Sale of KidsFoundation
SIG-COMBIBLOC-GROUP19.7.2018 18:03 | pressemeddelelse
SIG Combibloc Group Holdings S.à r.l.: 2018 Second Quarter Results
FL-NEORIS19.7.2018 17:34 | pressemeddelelse
NEORIS Announces Creation of Innovation Labs Worldwide to Create a Smarter Future
CQN-FLEXTRADE19.7.2018 17:31 | pressemeddelelse
CORRECTING and REPLACING Albar Capital Deploys FlexNOW
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum